- Sputnik International, 1920
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

Nicaragua Begins Inoculation of Population With Russia's Sputnik V COVID Vaccine - Reports

© RIA Novosti . Russian Direct Investment Fund (RDIF) / Go to the mediabankIn this handout photo released by Russian Direct Investment Fund, a view shows a fridge with packages of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia.
In this handout photo released by Russian Direct Investment Fund, a view shows a fridge with packages of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia.  - Sputnik International, 1920, 03.03.2021
Subscribe
MEXICO CITY (Sputnik) - Nicaragua has started inoculating the population with Russia's Sputnik V vaccine against the novel coronavirus disease (COVID-19), Prensa reported.

The report said that at the Cruz Azul Hospital in Managua, 62-year-old Marco Antonio Araus from Masaya - a patient with chronic renal failure and hypertension on hemodialysis therapy - became the first Nicaraguan to receive a COVID-19 vaccine.

The start of voluntary vaccination of citizens was announced on Tuesday by Vice President Rosario Murillo, but the Ministry of Health has not yet submitted an immunization plan and has not reported on the number of vaccines available.

Sputnik V was the world's first COVID-19 vaccine registered by Russian health authorities in August 2020 and was developed by the Gamaleya Epidemiology and Microbiology Center. It is built on the well-studied and proven platform of human adenoviral vectors.

The scientific journal Lancet previously published the results of the third phase of clinical trials "Sputnik V", confirming its high efficacy and safety at 91.6%. According to the study, the vaccine provides complete protection against severe cases of the novel coronavirus disease.

Sputnik V has been approved for use in 39 countries, including two EU members - Hungary and Slovakia.
Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала